Intermittent Catheter Market - Consumption, Export, Import by Regions, Competitors, Pricing Strategy, Brand Strategy

Worldwide Intermittent Catheter Market is valued at $ 1,665.5 million in 2016 and is expected to reach $ 295.7 million by 2023, an annual growth rate of 8.7% from 2017 to 2023. The women's catheter sector accounted for about half of the global market in 2016.

Intermittent catheters help drain the bladder from patients who can not control the bladder with medical equipment. These catheters are inserted into the urethra and directed into the bladder to flow urine through the catheter tube and into the collection bag. In addition, this catheter can be used to insert its own catheter. Children aged 7 to 8 can be trained to treat urinary catheterization.

The main factor in the intermittent catheter market is the increase in the elderly population and the increase in urinary incontinence. In addition, the introduction of catheter advantageous reimbursement policies is expected to complement market growth. However, intermittent catheter alternatives and domestic price competition are hampering market growth. Conversely, emerging economies are expected to provide profitable opportunities by increasing disposable income and increasing awareness of intermittent catheters.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3742

The key players operating in the global intermittent catheters market are

·         Adapta Medical

·         B. Braun Melsungen AG

·         Becton Dickinson Company

·         Coloplast A/S

·         ConvaTec Healthcare B S..r.l

·         Cure Medical

·         Hollister Inc.

·         Medical Technologies of Georgia Inc.

·         Pennine Healthcare

·         Teleflex Incorporated

Other players operating in the value chain are Hunter Urology, ASID BONZ, At Home Medical Products, Medical Technologies of Georgia and Hope Medical Supply Inc.

Among the product segment, uncoated intermittent catheters accounted for the maximum share in the global market, due to wide usage of uncoated catheters, owing to new materials used in the production of uncoated intermittent catheters to minimize allergies associated to latex material.

Among the indication segment, the urinary incontinence segment accounted for the maximum share, owing to increase in prevalence of urinary continence in both male and female population globally. For instance, urinary incontinence affects about 4-8% or 400 million individuals globally.

Make an Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3742

Key Findings of the Intermittent Catheters Market:

• The male length catheters segment accounted for about three-eighth share of the total market in 2016, and is expected to register a high CAGR of 8.4% from 2017 to 2023.
• The hospitals segment accounted for three-seventh share of the total market and is expected to grow at a CAGR of 8.6% during the forecast period.
• U.S. dominated the North American intermittent catheters market and is projected to grow at a CAGR of 7.0%.
• Australia is the fastest growing country in the Asia-Pacific intermittent catheters market during the forecast period, registering a CAGR of 11.0%.
• Ambulatory surgery centers accounted for one-third market share in 2016, and are expected to grow at a high CAGR of 8.9%.

In 2016, North America was the dominant revenue contributor, owing to high prevalence rate of urinary incontinence and surge in number of minimally invasive surgeries in the region. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the presence of high populace countries such as India and China, increase in awareness regarding intermittent catheters & urinary incontinence, and rise in disposable income.

Access Full Summery @ https://www.alliedmarketresearch.com/intermittent-catheters-market

PEGylated Protein Therapeutics Market Anticipated to Grow at an Impressive Rate during the Period

The PEGylated Protein Therapeutics Market is estimated at $ 1,038 million in 2017 and is projected to grow at an average annual rate of 6.9% from 2018 to 2025, reaching $ 17.813 billion by 2025. North America is expected to have the highest revenue contribution over the forecast period.

PEGylation is the process of adding active polyethylene glycol (PEG) to various forms of therapeutic proteins for chemical modification. These chemically modified therapeutic proteins are called PEGylated protein therapeutics. Chemical modification due to PEGylation brings about various advantages such as extended half-life of the drug with lower toxicity and increased proteolytic protection than the untreated protein therapeutic. PEGylated protein therapeutics are used in cancer, hemophilia, rheumatoid arthritis, ankylosing spondylitis, Crohn's disease and many other conditions.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3726

The report provides an extensive competitive analysis and profiles of the key market players such as

·         Amgen Inc.

·         AstraZeneca PLC

·         Biogen Inc.

·         F. Hoffmann-La Roche Ltd. (Genentech Inc.)

·         Horizon Pharma plc.

·         Leadiant Biosciences S.p.A.

·         Merck & Co. Inc. (Schering-Plough Corporation)

·         Pfizer Inc.

·         Shire plc (Baxalta)

·         UCB S.A.

The factors that drive the growth of the global PEGylated protein therapeutics market are increase in prevalence of chronic diseases, advantages offered by PEGylation, and strong presence of pipe line drugs are. However, high cost related to drug development and launch of generics during the forecast period are expected to impede the market growth. In addition, high market potential in the untapped emerging economies and increase in adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.

Make an Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3726

By product type, the colony stimulating factor segment accounted for nearly half share of the global occupational medicine market in 2017. Furthermore, the cancer segment is anticipated to grow at the highest rate of 7.4% during the forecast period.

Key Findings of the PEGylated Protein Therapeutics Market:

• North America occupied nearly two-thirds share of the global PEGylated protein therapeutics market in 2017
• The cancer segment is anticipated to grow with the highest CAGR throughout the forecast period.
• Europe is anticipated to occupy one-fifth market share of the global PEGylated protein therapeutics market by 2025.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to FDA approval and launch of new drugs in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 7.4% from 2018 to 2025, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward chronic disorders.

Access Full Summery @ https://www.alliedmarketresearch.com/PEGylated-proteins-market

IVF Services Market - Consumption, Export, Import by Regions, Competitors, Pricing Strategy, Brand Strategy

IVF Services Market in India was valued at $256.0 million in 2016, and is projected to reach $829.5 million by 2023, registering a CAGR of 18.2% from 2017 to 2023. Modern lifestyle, increase in infertility rate among couples, and rise in spending of middle class and higher class for IVF treatment are the major factors that boost the growth of the market.

In vitro fertilization (IVF) is an assisted reproductive technology (ART) procedure. It is the process of fertilization, which includes eggs extraction, sperm cell sample retrieval, and then manually combining an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the uterus for further gestation.

The India IVF services market is expected to witness a substantial growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, and increased occurrences of gamete donations. Furthermore, low cost clinical settings for IVF treatments in India when compared with IVF treatment facilities in the U.S., the UK, and other established markets, rise in popularity of medical and fertility tourism coupled with advanced IVF facilities & treatment options are anticipated to supplement the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2172

The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.).

Other players (profiles not included in the report) in the value chain analysis include, Apollo Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center., and others.

With respect to end users, the fertility clinics segment accounted for about 61% of the India IVF services market revenue in 2016, and is projected to maintain its dominance during the forecast period. In addition, this segment performed 77.4 thousand cycles in 2016, and is projected to reach 245.4 thousand by 2023, growing at a CAGR of 17.9%, thus accounting for the highest number of IVF cycles. This is attributed to the fact that fertility clinics provide technologically advanced and a wide range of fertility treatments under a single roof for patients.

Based on cycle type, the fresh IVF cycles segment (non-donor) generated the highest revenue of $187.1 million in 2016, and is expected to reach $606.6 million by 2023, growing at a CAGR of 18.2%. In addition, this segment was the largest segment in the India IVF services market, with 80.1 thousand fresh IVF cycles (non-donor) performed in 2016, and is expected to reach 239.6 thousand cycles by 2023, growing at a CAGR of 16.9% from 2017 to 2023.

Get Discount UP To 25% * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/checkout/240070

Key Findings of the India Ivf Services Market:

• Based on cycle type, in 2016, fresh IVF cycle (non-donor) segment accounted for around 70% share of the total market, in terms of revenue
• Thawed IVF cycle (non-donor) is projected to be the one of the fastest growing segments, registering a CAGR of 19.6% from 2017 to 2023, in terms of revenue
• Based on gender, in 2016, the female infertility segment, in terms of volume, accounted for more than 70% share of the total market.
• Based on IVF procedures, in 2016, non-ICSI IVF accounted for the highest revenue, thereby registering a CAGR of 19.2% from 2017 to 2023.

Access Full Summery @ https://www.alliedmarketresearch.com/india-ivf-services-market

Cytogenetic Market - With Future Growth By Top Players Involved In The Market

The Cytogenetic Market is estimated at $ 1,111 million in 2017 and is expected to reach $ 399 million in 2025, with an average annual growth rate of 13.5% from 2018 to 2025.

Cytogenetics is a field of biology that links cytology and genetics. Correlation is used to study the chromosomes and genes of cells and tissues. This work is done in relation to the number of chromosomes used in gene mutation and mutation and in the selection of the correct treatment for the detection of genetic diseases and the treatment of these genetic disorders. Cytogenetics includes a variety of techniques including comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, and immunohistochemistry. These techniques require the use of cytogenetic agents such as test kits, media and reagents. Probe; Expendables; instrument; and software and services. These products and technologies are used in the screening of genetic diseases and in the design of personal medicine.

Along with the proliferation of chronic diseases, an increase in the prevalence of cancer and hereditary diseases, an increase in the global elderly population, and a surge in awareness of the worldwide acceptance of customized medicines are leading factors in the growth of the global cytogenetics market. But the high cost of advanced cytogenetics equipment is expected to hamper market growth. Conversely, the transition from fish to array-based technology is expected to provide many opportunities during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2116

The utilization rate of testing kits, media, and reagents is high, as they are the essential elements of every cytogenetic technique performed. However, the software & services segment is expected to grow at a high CAGR during the forecast period.

The key players of this market include

·         Abbott Laboratories

·         Agilent Technologies Inc.

·         Applied Spectral Imaging Inc.

·         Empire Genomics LLC.

·         Illumina Inc.

·         Irvine Scientific.

·         OPKO Health Inc. (GeneDx.)

·         PerkinElmer Inc.

·         Sysmex Corporation (Oxford Gene Technology)

·         Thermo Fisher Scientific Inc.

Other players (these players are not profiled in the report and the same can be included on request) in the value chain include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and MetaSystems.

Get Discount UP To 25% * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/checkout/570017

The comparative genomic hybridization segment is the largest segment in the global cytogenetics market, and is anticipated to grow at a high CAGR during the forecast period. The clinical & research laboratories segment is expected to grow at a moderate CAGR in the near future. On the other hand, the pharmaceutical & biotechnology companies segment is anticipated to record a high CAGR during the forecast period.

Key findings of the Cytogenetics Market:

• The testing kits, media, and reagents segment accounted for approximately three-fourths share of the global cytogenetics consumables market in 2017.
• The comparative genomic hybridization segment is expected to grow at a CAGR of 10.5% from 2018 to 2025.
• North America accounted for the majority of the share of the global market revenue in 2017.
• Asia-Pacific is expected to provide lucrative market growth opportunities, registering a CAGR of 12.1% from 2018 to 2025.

North America was the leading revenue contributor to the global cytogenetics market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the presence of majority of major key players in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to increase in affordability, surge in healthcare expenditure, and rise in awareness towards early screening of genetic disorders.

Access Full Summery @ https://www.alliedmarketresearch.com/cytogenetics-market

Balkan TMT steel bar Market Anticipated to Grow at an Impressive Rate during the Period

The Balkan TMT steel bar market is valued at $ 1,767 million in 2017 and is expected to reach $ 4,065 million by 2024, with an annual average growth rate of 12.5% ​​from 2018 to 2024. The market size is 2017 2,669,000 tonnes per year and is expected to reach 5,435 tonnes by 2024 and is expected to grow at an annual average rate of 10.6% from 2018 to 2024.

TMT steel bars are high-quality reinforced steel bars routinely used in the infrastructure and construction industries due to their significant physical properties such as ductility, toughness and corrosion resistance.

The Balkan TMT steel bar market is expected to increase considerably in the near future due to a variety of factors including the development of the Balkan region and the benefits offered by the TMT bar rather than the torsional bar. The support and cooperation of the EU for the development of the coal and steel industry in the Balkans also complements the growth of the market. However, technological constraints associated with advanced TMT bars are expected to hamper market growth. On the contrary, in the Balkan industry, investment growth in countries like China is expected to provide potential growth opportunities for market participants during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4675

The report provides an extensive competitive analysis and profiles of the key market players such as

·         ArcelorMittal Zenica

·         Balkan Steel Engineering Ltd.

·         Essar Steel

·         HBIS Group

·         HUS Ltd.

·         Metalopromet d. o. o. Kula

·         MMD

·         SIDERAL S.H.P.K.

·         SIJ Group

·         TATA Steel.

The other players in the value chain (not included in the report) include Eurometal Bulgaria Ltd., Ovako Bulgaria, and Metalfer Group.

Get Discount UP To 25% * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/checkout/796470

According to grade, in 2017, the FE-415 grade TMT steel bars accounted for more than two-thirds share of the market, in terms of volume. By application, the residential application segment garnered nearly one-fourth of the market share by value in 2017, and is projected to exhibit prominent growth rate, owing to surge in construction of housing & residential projects in the Balkans.

Depending on the diameter segment, the TMT bars having diameter of 12 mm & above generated the highest revenue in 2017, due to their widespread application in reinforced concrete columns.

Key Findings of the Balkans TMT Steel Bar Market :

• The Fe 415 grade TMT steel bars accounted for the largest revenue in the Balkans TMT steel bar market in 2017.
• Commercial application is anticipated to grow with the highest CAGR throughout the forecast period.
• By volume, Albania accounted for nearly one-sixth share of the Balkans TMT steel bar market in 2017.
• Kosovo is anticipated to grow at the highest rate during the analysis period, followed by Bosnia and Herzegovina.

Albania was the leading revenue contributor to the Balkan market in 2017, owing to high adoption rate of TMT steel bars and rise in construction projects such as the National Arena Stadium in Tirana, construction of the Trans Adriatic Pipeline, and others. However, Kosovo is expected to grow at the highest CAGR of 15.0% from 2018 to 2025, due increase in government and private sector initiatives to improve the energy infrastructure, connectivity & transportation, and development in this region.

Access Full Summery @ https://www.alliedmarketresearch.com/balkans-TMT-steel-bar-market   

GCC's Market - Consumption, Export, Import by Regions, Competitors, Pricing Strategy, Brand Strategy

GCC's market for extruded polystyrene insulation materials is estimated at $ 80.5 million in 2016 and is expected to reach $ 109.9 million in 2023, an annual CAGR of 6.0% from 2017 to 2023.

 Extruded polystyrene (XPS) insulation offers excellent long-term strength, durability and moisture resistance. It is generally used in waterproof and roof systems of the following grades, and the insulation is placed on the roof membrane. The XPS foam sheath provides insulation across the entire wall and reduces air leakage through the wall during proper installation. This in turn improves energy efficiency and comfort. In addition, XPS foam is better than other insulating materials because it supports moisture management and resistance to water absorption and freeze / thaw cycles.

 The growth of the GCC extruded polystyrene insulation industry is driven by the increased demand for XPS in the non-residential construction sector, the popularization of energy-efficient building systems and the benefits of using XPS for other reinforcement materials. However, environmental issues related to the presence of toxic chemicals in XPS material systems can hinder market growth. As research and development activities to produce high-quality XPS without using greenhouse gases are increasing as bubbles, potential growth opportunities in the market are expected to be provided in the near future.

 Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4564

 The key players profiled in the report are

·         Styro Insulation Material Ind. (LLC)

·         Isofoam Engineering Products

·         National Polystyrene Packaging Factory LLC

·         Emirates Extruded Polystyrene LLC

·         Electronic & Engineering Industries Co. LLC (EEI)

·         Styrene Insulation Industry

·         Thermal Insulation Contracting LLC

·         BASF SE

·         Kingspan Holdings Ltd.

·         Compagnie de Saint-Gobain S.A.

The residential construction segment is projected to grow at the highest CAGR throughout the forecast period. The nonresidential segment accounted for more than 50% share in 2016, owing to the increase in demand for insulated commercial buildings. Nonresidential construction includes retail stores, commercial offices, factories, warehouses, power stations, cold stores, food processing plants, telecom shelters, and public institutions such as schools and hospitals.

 Get Discount UP To 25% * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/checkout/91024

 Key Findings of the GCC Extruded Polystyrene Insulation Materials Market:

• In 2016, UAE contributed the maximum revenue to the GCC extruded polystyrene insulation materials market, accounting for more than 53.2% share.
• Bahrain is expected to register the highest CAGR of 8.3% from 2017 to 2023.
• The residential construction segment accounted for approximately 43.6% share of the overall market in 2016, and is expected to grow at a CAGR of 6.4% from 2017 to 2023.

 Access Full Summery @ https://www.alliedmarketresearch.com/GCC-extruded-polystyrene-insulation-materials-market